Detalhe da pesquisa
1.
KEYNOTE-033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC.
Int J Cancer
; 153(3): 623-634, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37141294
2.
A new era of the Asian clinical research network: a report from the ATLAS international symposium.
Jpn J Clin Oncol
; 53(7): 619-628, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099440
3.
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
Lancet
; 397(10274): 592-604, 2021 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33581821
4.
The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium.
Cancer Sci
; 112(3): 1095-1104, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393133
5.
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 188(2): 369-377, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125340
6.
Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis.
BMC Cancer
; 21(1): 1275, 2021 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34823493
7.
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.
Int J Clin Oncol
; 26(5): 841-850, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33783657
8.
The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.
Int J Clin Oncol
; 25(2): 396-402, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776732
9.
Incidence of infusion hypersensitivity reaction after withholding dexamethasone premedication in early breast cancer patients not experiencing two previous cycles of infusion hypersensitivity reaction for weekly paclitaxel chemotherapy.
Support Care Cancer
; 26(7): 2471-2477, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29435713
10.
A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes.
Chemotherapy
; 62(2): 134-139, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27997900
11.
Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
JAMA
; 317(1): 37-47, 2017 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27918780
12.
SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis).
J Neurooncol
; 129(3): 395-403, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401153
13.
The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrence.
Int J Clin Oncol
; 19(4): 586-92, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23824557
14.
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial.
Lancet Oncol
; 14(8): 777-86, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23782814
15.
Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer.
Sci Rep
; 14(1): 6146, 2024 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480816
16.
Development of Clinical Prediction Score for Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients.
Healthcare (Basel)
; 11(3)2023 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36766868
17.
Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac.
Vaccines (Basel)
; 11(2)2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851234
18.
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis.
Cancer Res Treat
; 55(1): 83-93, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344649
19.
EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observational open-label pilot study.
Endosc Ultrasound
; 12(5): 402-408, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37969163
20.
Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial.
J Thorac Oncol
; 18(9): 1209-1221, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37236398